Abiopharma

🔍 Valdez Joshua James (Executive)

Company: CCC Intelligent Solutions Holdings Inc. (CCC)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 159,745 shares of Common Stock (Direct)
  Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 159,745.00 | transaction_form_type: 4
• Sold 58,055 shares of Common Stock at $4.7 per share (Direct)
  Date: 2026-06-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 101,690.00 | transaction_form_type: 4
• Sold 159,745 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 159,744.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The Reporting Person was granted Restricted Stock Units (the "Valdez RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each Valdez RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the Valdez RSU, or (iii) a combination thereof. One-half (50%) of the Valdez RSUs will vest on June 6, 2026, and one-sixth (16.66%) of the Valdez RSUs vest upon each of the first three anniversaries of the Grant Date, generally subject to the Reporting Person's continued service to the Issuer through each such vesting and settlement date.
• REMARKS: Senior Vice President, Chief Product Officer